Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Mar
19
2020
Coronavirus (COVID-19) Temporary Advisory Notice: Breaking Down the Latest Guidance From the Pennsylvania Liquor Control Board Norris McLaughlin P.A.
Mar
19
2020
COVID-19: Implications for Pharmaceutical and Medical Device Companies Dinsmore & Shohl LLP
Mar
19
2020
FDA Issues Guidance for Ongoing Clinical Trials During COVID-19 Pandemic Epstein Becker & Green, P.C.
Mar
19
2020
The Fun Did Stop for Pringles False Advertising Class Action Proskauer Rose LLP
Mar
19
2020
Families First Coronavirus Response Act: Guidance for Health Care Providers and Plans Regarding COVID-19 Epstein Becker & Green, P.C.
Mar
19
2020
COVID-19 Telehealth Guidance: What You Need to Know McDermott Will & Emery
Mar
18
2020
Ohio Department Of Health Orders Cancellation of All Non-Essential Surgeries to Preserve PPE Dinsmore & Shohl LLP
Mar
18
2020
DEA Allows Providers to Prescribe Controlled Substances Without an In-Person Medical Examination During COVID-19 Public Health Emergency Robinson & Cole LLP
Mar
18
2020
Gov. Roy Cooper Orders Restaurants and Bars to Close Dine-In Service, Announces New Help for Unemployed Ward and Smith, P.A.
Mar
18
2020
CMS Rolls Out Part D Insulin Payment Model: Aims to Lower Out-of-Pocket Expenses McDermott Will & Emery
Mar
18
2020
COVID-19: DEA Confirms Public Health Emergency Exception for Telemedicine Prescribing of Controlled Substances Foley & Lardner LLP
Mar
18
2020
FDA’s Congressional Report Confirms Slow But Steady Progress on CBD Regulation Bilzin Sumberg
Mar
18
2020
EDNY Passes on Potatoes Lawsuit Proskauer Rose LLP
Mar
18
2020
2019 In Review: Overview Of Cartel Investigations McDermott Will & Emery
Mar
18
2020
#WorkforceWednesday: COVID-19 Pandemic, Election Rules Challenged, EEOC Limits GC’s Authority Epstein Becker & Green, P.C.
Mar
18
2020
EPA Will Amend CDR Rule and Extend 2020 Submission Period Bergeson & Campbell, P.C.
Mar
18
2020
US District Court Orders USDA to Revise Errors Related to Organic Animal Welfare Rule Withdrawal Keller and Heckman LLP
Mar
18
2020
FDA Issues Final Guidance On Third-Party Review Of 510(K) Applications Barnes & Thornburg LLP
Mar
17
2020
Bipartisan Congress Intensifies Efforts to Restrict Orphan Drug Exclusivity Proskauer Rose LLP
Mar
17
2020
Illumina v. Ariosa – The “Bucket” to be in
Mar
17
2020
Recent Federal Developments - FDA - March 2020 Bergeson & Campbell, P.C.
Mar
17
2020
Massachusetts Issues COVID-19 Guidance for Health Care Providers, Payors and Laboratories on Issues Including Telehealth, Elective Procedures, COVID-19 Testing, and Expedited Provider Licensure Robinson & Cole LLP
Mar
17
2020
Congress Considers Expansive Coronavirus Package, Including Paid Leave and Free Testing Faegre Drinker
Mar
17
2020
Managing the Commercial Impact of the Coronavirus: FAQs for the Life Sciences Industry Foley & Lardner LLP
Mar
17
2020
Pennsylvania Liquor Control Board Shuts Down Special Orders of Wine and Spirits: A Coronavirus (COVID-19) Update Norris McLaughlin P.A.
Mar
17
2020
Clean Hands Can Stop More than COVID-19: Antitrust Risks in Times of Supply and Demand Shocks McDermott Will & Emery
Mar
17
2020
FDA Grants COVID-19 Diagnostic Emergency Use Authorizations, And Other Recent FDA Actions to Address COVID-19 Sheppard, Mullin, Richter & Hampton LLP
Mar
17
2020
Implications of COVID-19 on Your Health and Welfare Benefit Plans Jackson Lewis P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins